High density lipoprotein natural history, complications and prognosis
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
High density lipoprotein natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of High density lipoprotein natural history, complications and prognosis |
|
FDA on High density lipoprotein natural history, complications and prognosis |
|
CDC on High density lipoprotein natural history, complications and prognosis |
|
High density lipoprotein natural history, complications and prognosis in the news |
|
Blogs on High density lipoprotein natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
The plasma levels of HDL are inversely proportional to the development of coronary artery disease (CAD) making HDL a positive cardiac risk factor. Low serum HDL-cholesterol can be an isolated abnormality or can be associated with hypercholesterolemia. Patients with premature coronary artery disease, defined as CAD in men less than 55 to 60 years of age and women less than 65 years of age, have a primary reduction in HDL-cholesterol. Studies have shown that low HDL risk is independent of the risk attributed to elevated LDL-cholesterol (low density lipoprotein) in the serum.